Pharming Group N.V. ADS, each representing 10 Share Price
NASDAQ: PHAR$12.01
+$12.01 (--%) Last updated on 18 Nov, 2026 | 02:22 ISTPharming Group N.V. ADS, each representing 10 Stock Performance
Pharming Group N.V. ADS, each representing 10 Share Price Chart
$0.00$0.00
L
H
Pharming Group N.V. ADS, each representing 10 Annual Profit & Loss
All figures in USD
About Pharming Group N.V. ADS, each representing 10
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Pharming Group N.V. ADS, each representing 10 Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $12.77 | $12.01 | -0.91% |
Oct 2026 | $9.81 | $12.12 | +10.74% |
Sep 2026 | $10.70 | $10.95 | -7.13% |
Aug 2026 | $10.66 | $11.79 | +12.02% |
Jul 2026 | $14.36 | $10.52 | -21.93% |
Jun 2026 | $12.84 | $13.47 | +6.35% |
May 2026 | $16.32 | $12.67 | -25.78% |
Apr 2026 | $17.11 | $17.07 | +3.64% |
Mar 2026 | $16.14 | $16.47 | +1.42% |
Feb 2026 | $16.61 | $16.24 | -20.71% |
Jan 2026 | $17.10 | $20.48 | +18.38% |
Dec 2025 | $16.65 | $17.30 | +5.88% |